Time to surgery in patients with breast cancer during the COVID-19 pandemic
Br J Surg
.
2020 Sep;107(10):e419-e421.
doi: 10.1002/bjs.11861.
Epub 2020 Jul 31.
Authors
Jiqiao Yang
1
,
Zhoukai Fu
1
,
Liang Du
2
,
Xiujing He
3
,
Xiusong Li
4
,
Jie Chen
1
Affiliations
1
Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
2
Chinese Evidence-Based Medicine Center/West China Medical Publishers, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
3
Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
4
Department of Clinical Medicine, Fujian Medical University, Fuzhou, People's Republic of China.
PMID:
32735686
PMCID:
PMC7929339
DOI:
10.1002/bjs.11861
No abstract available
Publication types
Letter
MeSH terms
Adult
Breast Neoplasms / surgery*
COVID-19* / epidemiology
China / epidemiology
Female
Humans
Middle Aged
Pandemics
SARS-CoV-2
Time-to-Treatment*